Create a free QxMD account to receive personalized paper recommendations, relevant to your practice.

Get Started

LETTER

Controversial issues in thromboprophylaxis with low-molecular weight heparins in palliative care

Davide Tassinari, Carlotta Santelmo, Emanuela Scarpi, Paola Tombesi, Sergio Sartori

Journal of Pain and Symptom Management 2008, 36 (2): e3-4

No abstract text is available yet for this article.

Full Text Links

Find Full Text Links for this Article

You are not logged in. Sign Up or Log In to join the discussion.

Low-molecular-weight heparin for thromboprophylaxis. Giuseppe Camporese, Enrico Bernardi Current Opinion in Pulmonary Medicine 2009, 15 (5): 443-54

Efficacy of obstetric thromboprophylaxis and long-term risk of recurrence of venous thromboembolism. Pelle G Lindqvist, Katarina Bremme, Margareta Hellgren Acta Obstetricia et Gynecologica Scandinavica 2011, 90 (6): 648-53

Anticoagulants for thrombosis prophylaxis following surgery: a continuing saga. Joseph A Caprini Thrombosis and Haemostasis 2008, 99 (6): 993-4

Risks and benefits of low molecular-weight heparin and target-specific oral anticoagulant use for thromboprophylaxis in medically ill patients. Genevieve Hale, Michael Brenner American Journal of Cardiovascular Drugs: Drugs, Devices, and Other Interventions 2015, 15 (5): 311-22

Low-molecular-weight heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review. Christine Ribic, Wendy Lim, Deborah Cook, Mark Crowther Journal of Critical Care 2009, 24 (2): 197-205

Make the most of Read.
Download the mobile app.

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

Read